scholarly journals Management of Chronic Portal Vein Thrombosis in a Cirrhotic Patient With Pancytopenia and Grade II Esophageal Varices

Cureus ◽  
2022 ◽  
Author(s):  
Ahmed Ali Aziz ◽  
Daoyu Yang ◽  
Muhammad Naeem ◽  
Donald Christmas
Keyword(s):  
Portal Vein ◽  
Portal Vein Thrombosis ◽  
Cirrhotic Patient ◽  
Esophageal Varices ◽  
Vein Thrombosis ◽  
Grade Ii

Percutaneous Transsplenic Embolization of Esophageal Varices in a 5-Year-Old Child

1987 ◽  
Vol 28 (3) ◽  
pp. 299-301 ◽  
Author(s):  
G. Rasinska ◽  
K. Wermenski ◽  
P. Rajszys
Keyword(s):  
Portal Vein ◽  
Portal Vein Thrombosis ◽  
Gastrointestinal Hemorrhage ◽  
Esophageal Varices ◽  
Splenic Vein ◽  
Endoscopic Sclerotherapy ◽  
Vein Thrombosis

A five-year-old girl with portal vein thrombosis and severe gastrointestinal hemorrhage recurring after repeated endoscopic sclerotherapy was successfully embolized via an ultrasonically guided transsplenic catheterization of the splenic vein.

scholarly journals Acute TIPS occlusion due to iatrogenic arteriovenous shunt in a cirrhotic patient with total portal vein thrombosis

2015 ◽  
Vol 7 (4) ◽  
pp. 166-170
Author(s):  
Adam Hatzidakis ◽  
Elias Kouroumalis ◽  
Elias Kehagias ◽  
Emmanuel Digenakis ◽  
Dimitrios Samonakis ◽  
...  
Keyword(s):  
Portal Vein ◽  
Portal Vein Thrombosis ◽  
Cirrhotic Patient ◽  
Arteriovenous Shunt ◽  
Vein Thrombosis

Acute Esophageal Varices and Portal Hypertension Secondary to Portal Vein Thrombosis

2011 ◽  
Vol 106 ◽  
pp. S187
Author(s):  
Akash Ferdaus ◽  
Kelly Cervellione ◽  
Avani Patel ◽  
Thomas Santucci ◽  
Richard Pinsker
Keyword(s):  
Portal Hypertension ◽  
Portal Vein ◽  
Portal Vein Thrombosis ◽  
Esophageal Varices ◽  
Vein Thrombosis

Portal Vein Thrombosis as a Cause of Massive Ascites in a Non-cirrhotic Patient

2015 ◽  
Vol 110 ◽  
pp. S388
Author(s):  
Carolina Bernabe Ramirez ◽  
Isabel Preeshagul ◽  
Jose G. Sanchez ◽  
Jeffrey A. Shrensel ◽  
Matthew Kutner ◽  
...  
Keyword(s):  
Portal Vein ◽  
Portal Vein Thrombosis ◽  
Cirrhotic Patient ◽  
Massive Ascites ◽  
Vein Thrombosis

scholarly journals Nontumorous Portal Vein Thrombosis in Liver Cirrhosis: Possible Role of β-Blockers

2018 ◽  
Vol 27 (5) ◽  
pp. 466-471 ◽  
Author(s):  
Lydia Giannitrapani ◽  
Walter Granà ◽  
Anna Licata ◽  
Cosima Schiavone ◽  
Giuseppe Montalto ◽  
...  
Keyword(s):  
Logistic Regression ◽  
Regression Analysis ◽  
Liver Cirrhosis ◽  
Portal Vein ◽  
Portal Vein Thrombosis ◽  
Logistic Regression Analysis ◽  
Esophageal Varices ◽  
Univariate Analysis ◽  
Vein Thrombosis ◽  
Β Blockers

Objective: Nonselective β-blockers (NSBB) are used in liver cirrhosis (LC) to prevent variceal bleeding because they decrease portal pressure. A main risk factor for the development of portal vein thrombosis (PVT) in LC is decreased portal vein inflow velocity. The aim of our study was to examine retrospectively the incidence of PVT and its correlation with the use of β-blockers in a cohort of LC patients. Subjects and Methods: Data from 230 LC patients (90% Child-Pugh class A), who had been followed up for at least 5 years, were reviewed. The diagnosis of PVT was made by ultrasound. The presence of PVT was evaluated with multiple logistic regression analysis where the independent variables were those significant in the univariate analysis. Results: The prevalence of PVT at baseline was 4.5%, and the incidence was 4.3% at 5 years; among the subjects taking β blockers, 46.4% were taking NSBB. A total of 19 PVT cases were found. Grade of esophageal varices (p < 0.01), PLT (p < 0.003), INR (p < 0.03), spleen diameter (p < 0.001) and PLT/spleen ratio (p < 0.0005) were significantly associated with PVT. The use of NSBB indicated a higher risk of PVT compared to selective β-blockers (SBB) (p < 0.05). In logistic regression analysis only the grade of esophageal varices was significant (p < 0.02). Univariate analysis of patients taking β-blockers showed an association of PVT with grade of esophageal varices (p < 0.01), CP class (p < 0.02), AST (p < 0.03), ALT and albumin (p < 0.02), PLT count and PLT/LD (p < 0.03), longitudinal diameter of the spleen (p < 0.005), ascites (p < 0.05), portal vein (p < 0.0001) and NSBB (OR 8.1; 95% CI 1.7–38.8). Conclusion: NSBB seem to play a role in PV thrombogenesis. Further studies are needed, especially in decompensated LC patients.

Sign in / Sign up

Export Citation Format

Share Document